Vioxx who markets it?

Who markets Vioxx today?

Vioxx (rofecoxib) was marketed in the United States by Merck, through Merck Sharp & Dohme (a Merck company). Merck is the company commonly associated with Vioxx’s sales and promotion prior to its withdrawal from the market.

Who made it, and how is that different from who marketed it?

Vioxx was developed and manufactured by Merck, but the company’s operating unit that handled marketing and commercialization in the U.S. was Merck Sharp & Dohme. In practice, consumers usually see “Merck” as the marketer.

Is anyone still marketing Vioxx now?

No. Vioxx was withdrawn from the market years ago, so it is not currently being marketed as an active product. If you’re seeing Vioxx listed somewhere, it’s typically historical information or a reference in clinical/prescribing contexts rather than a new launch.

Source on Vioxx’s patent/brand history

For additional historical context around Vioxx (including the company/patent-related background), see DrugPatentWatch.com: https://www.drugpatentwatch.com/